| View |
|
DRP-12149
|
Moxifloxacin (As Hydrochloride)
|
Moxiflo
|
1.6 mg/mL (400 mg/250 mL)
|
Solution for Intravenous Infusion
|
Antibacterial (Fluoroquinolone)
|
Sui Guan Chem. Ind. Co., Ltd.
|
Taiwan
|
Initial
|
21 June 2022
|
21 June 2027
|
| View |
|
DRP-12144
|
Amlodipine (as Besilate)
|
Amlosaph-5
|
5 mg
|
Tablet
|
Calcium Channel Blocker
|
Sapphire Lifesciences Pvt. Ltd
|
India
|
Initial
|
22 June 2022
|
22 June 2027
|
| View |
|
DRP-12210
|
Micajub
|
Telmisartan
|
80 mg
|
Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Jubilant Generics Limited
|
India
|
Initial
|
30 June 2022
|
30 June 2027
|
| View |
|
DRP-12186
|
Salbutamol (As Sulfate)
|
Asmalin
|
2 mg/5 mL
|
Syrup
|
-
|
Amherst Laboratories, Inc.
|
Philippines
|
Initial (Variation)
|
28 June 2022
|
28 June 2027
|
| View |
|
DR-XY48140
|
Ciprofloxacin
|
Ciclodin IV
|
2 mg/mL (200 mg/100 mL)
|
Solution for IV Injection
|
Antibacterial (Fluoroquinolone)
|
HK inno.N Corporation
|
Korea
|
Initial (Correction)
|
26 June 2024
|
28 June 2027
|
| View |
DR-XY48112_PI_01.pdf
|
DR-XY48112
|
Granisetron (as hydrochloride)
|
Kytron
|
1mg/mL (3 mg/3mL)
|
Solution for Injection/Infusion
(I.M./I.V.)
|
Antiemetic and Antinauseant
|
Duopharma (M) Sdn. Bhd.
|
Malaysia
|
Initial (Correction)
|
18 October 2022
|
30 June 2027
|
| View |
|
DRP-12147
|
Dexamethasone Phosphate (as sodium)
|
Dexahab
|
5mg/mL
|
Solution For Injection (I.M./I.V.)
|
Corticosteroid
|
Union Korea Pharm Co., Ltd.
|
Korea
|
Initial
|
22 June 2022
|
22 June 2027
|
| View |
|
DRP-12142
|
Potassium Chloride
|
Electab
|
750 mg
|
Extended-Release Tablets
|
Mineral
|
Globela Pharma Pvt. Ltd.
|
India
|
Initial
|
20 June 2022
|
20 June 2027
|
| View |
|
DRP-12143
|
Potassium Chloride
|
Electab
|
600 mg
|
Extended-Release Tablets
|
Mineral
|
Globela Pharma Pvt. Ltd.
|
India
|
Initial
|
20 June 2022
|
20 June 2027
|
| View |
|
DRP-8071-01
|
Cholecalciferol + Calcium (as Carbonate) 400 IU/600 mg Film-coated Tablet
|
Caltradin
|
400IU/600mg
|
Film-coated Tablet
|
Vitamin and Mineral
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
03 January 2024
|
15 January 2029
|
| View |
|
DRP-11209-01
|
Ampicillin (as sodium) + Sulbactam (as sodium)
|
Ansulmed
|
1 g/500 mg
|
Powder for Injection (I.V./I.M.)
|
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
|
Reyoung Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
29 July 2022
|
15 February 2027
|
| View |
|
DRP-11162-01
|
Piperacillin (as sodium) + Tazobactam (as sodium)
|
Nosamax 4.5
|
4g/500mg
|
Powder for Injection (I.V.)
|
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
27 July 2022
|
08 February 2027
|
| View |
|
DRP-11344-01
|
Vancomycin Hydrochloride
|
Vancosar 1000
|
1 g
|
Powder for Injection (I.V.)
|
Antibacterial
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
CLIDP Conversion
|
23 July 2022
|
03 March 2027
|
| View |
|
DRP-10736-01
|
Olmesartan medoxomil
|
OlmeGet
|
20 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker (ARB)
|
Hetero Labs Limited (Unit V)
|
India
|
CLIDP Conversion
|
22 July 2022
|
15 November 2026
|
| View |
|
DRP-9054-01
|
Cefotaxime (as sodium)
|
Tergen
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Third-Generation Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
13 July 2022
|
31 October 2025
|
| View |
|
DRP-10961-02
|
Ceftriaxone (as sodium)
|
CEFTRIOVINN
|
1g
|
Powder for Injection
|
Antibacterial (Third-generation Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
12 July 2022
|
22 December 2026
|
| View |
|
DR-XY37556
|
Glimepiride
|
Norizec
|
2mg
|
Tablet
|
Sulfonylurea
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
08 July 2022
|
09 July 2027
|
| View |
|
DRP-11547-01
|
Paracetamol
|
Paracent
|
10 mg / mL ( 1g / 100 mL)
|
Solution for Injection (IV Infusion)
|
Analgesic / Anti-pyretic (Anilide)
|
Genuone Sciences Inc.
|
Korea
|
CLIDP Conversion
|
08 July 2022
|
30 March 2027
|
| View |
|
DRP-5930-03
|
Omeprazole Sodium
|
Ovint
|
40 mg
|
Lyophilized Powder for Injection
|
Proton Pump Inhibitor
|
FUREN PHARMACEUTICAL GROUP CO., LTD
|
China
|
Renewal
|
13 September 2023
|
05 December 2028
|
| View |
|
DRP-11801-02
|
Cefuroxime (as Sodium)
|
Gemicef
|
750mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Furen Pharmaceutical Group Co., Ltd.
|
China
|
CLIDP Conversion
|
08 July 2022
|
29 April 2027
|